Neuroprotective Effects of Neuropeptide Y on Human Neuroblastoma SH-SY5Y Cells in Glutamate Excitotoxicity and ER Stress Conditions

Cells. 2022 Nov 18;11(22):3665. doi: 10.3390/cells11223665.

Abstract

Neuropeptide Y (NPY), a sympathetic neurotransmitter, is involved in various physiological functions, and its dysregulation is implicated in several neurodegenerative diseases. Glutamate excitotoxicity, endoplasmic reticulum (ER) stress, and oxidative stress are the common mechanisms associated with numerous neurodegenerative illnesses. The present study aimed to elucidate the protective effects of NPY against glutamate toxicity and tunicamycin-induced ER stress in the human neuroblastoma SH-SY5Y cell line. We exposed the SH-SY5Y cells to glutamate and tunicamycin for two different time points and analyzed the protective effects of NPY at different concentrations. The protective effects of NPY treatments were assessed by cell viability assay, and the signalling pathway changes were evaluated by biochemical techniques such as Western blotting and immunofluorescence assays. Our results showed that treatment of SH-SY5Y cells with NPY significantly increased the viability of the cells in both glutamate toxicity and ER stress conditions. NPY treatments significantly attenuated the glutamate-induced pro-apoptotic activation of ERK1/2 and JNK/BAD pathways. The protective effects of NPY were further evident against tunicamycin-induced ER stress. NPY treatments significantly suppressed the ER stress activation by downregulating BiP, phospho-eIF2α, and CHOP expression. In addition, NPY alleviated the Akt/FoxO3a pathway in acute oxidative conditions caused by glutamate and tunicamycin in SH-SY5Y cells. Our results demonstrated that NPY is neuroprotective against glutamate-induced cell toxicity and tunicamycin-induced ER stress through anti-apoptotic actions.

Keywords: SH-SY5Y cells; glutamate excitotoxicity; neurodegeneration; neuropeptide Y; neuroprotection; oxidative stress; tunicamycin-induced ER stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Glutamic Acid / toxicity
  • Humans
  • Neuroblastoma*
  • Neuropeptide Y / pharmacology
  • Neuroprotective Agents* / pharmacology
  • Tunicamycin / pharmacology

Substances

  • Neuroprotective Agents
  • Neuropeptide Y
  • Glutamic Acid
  • Tunicamycin

Grants and funding

This research was funded by National Health and Medical Research Council (NHMRC) of Australia, Perpetual Hillcrest, Australian Vision Research (AVR), and Macquarie University, NSW, Australia.